Advertisement

International Ophthalmology

, Volume 39, Issue 12, pp 2883–2888 | Cite as

Clinical diversity in macular corneal dystrophy: an optical coherence tomography study

  • Sunita ChaurasiaEmail author
  • Muralidhar Ramappa
  • Dilip Kumar Mishra
Original Paper
  • 64 Downloads

Abstract

Purpose

To characterise the corneal deposits of macular corneal dystrophy and correlate with high-resolution optical coherence tomography (OCT).

Methods

A total of 23 eyes of 15 patients were evaluated for clinical features on slit lamp biomicroscopy, and high-resolution OCT was performed to correlate the clinical findings. The deposits were characterised based upon their location and level in the corneal layers.

Results

Mean age was 31.5 (Range 20–67) years. The stromal deposits were restricted to central 8 mm in 9 eyes; in the rest of the 14 eyes, the deposits were seen in both central and peripheral cornea. In one patient, no such distinction could be made due to diffuse nature of the deposits throughout the cornea with sparing of 1–2 mm of the cornea internal to the limbus. The central deposits were in the anterior stromal layers, while the peripheral deposits were in the deep stromal corneal layers and non-contiguous with the anterior stromal deposits. In one patient aged 67 years, the peripheral deposits in deep corneal layers were more prominent than the central anterior stromal deposits and were associated with a significant thickening of Descemet membrane.

Conclusions

MCD exhibits a clinically diverse presentation as revealed on the clinical and optical coherence tomography study. Immunophenotype and genotype–phenotype correlation may further help in understanding various clinical presentations of MCD.

Keywords

Macular corneal dystrophy Corneal dystrophy Optical coherence tomography 

Notes

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

References

  1. 1.
    Weiss JS, Moller HU, Lisch W et al (2008) The IC3D classification of the corneal dystrophies. Cornea 27:S1–83PubMedPubMedCentralGoogle Scholar
  2. 2.
    Morgan G (1966) Macular dystrophy of the cornea. Br J Ophthalmol 50:57CrossRefGoogle Scholar
  3. 3.
    Snip RC, Kenyon KR, Green WR (1972) Macular corneal dystrophy: ultrastructural pathology of corneal endothelium and Descemet’s membrane. Investig Ophthalmol Vis Sci 12:88–97Google Scholar
  4. 4.
    Hassel JR, Newsome DA, Krachmer JH et al (1980) Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan. Proc Natl Acad Sci USA 77:3705–3709CrossRefGoogle Scholar
  5. 5.
    Rubinstein Y, Weiner C, Einan-Lifshitz A et al (2015) Macular corneal dystrophy and posterior corneal abnormalities. Cornea 34:171–176CrossRefGoogle Scholar
  6. 6.
    Chaurasia S, Mishra DK (2019) Atypical presentation of macular corneal dystrophy managed by Descemet stripping endothelial keratoplasty. Indian J Ophthalmol 67(1):118–119CrossRefGoogle Scholar
  7. 7.
    Gruenauer-Kloevekorn C, Braeutigam S, Heinritz W et al (2008) Macular corneal dystrophy: mutation spectrum in German patients, novel mutations and therapeutic options. Graefes Arch Clin Exp Ophhalmol 246:1441–1447CrossRefGoogle Scholar
  8. 8.
    Nowinska AK, Wylegala E, Teper S et al (2014) Phenotype and genotype analysis in patients with macular corneal dystrophy. BJO 98:1514–1521CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  • Sunita Chaurasia
    • 1
    Email author
  • Muralidhar Ramappa
    • 1
  • Dilip Kumar Mishra
    • 2
  1. 1.Cornea and Anterior Segment ServicesL.V. Prasad Eye InstituteHyderabadIndia
  2. 2.Ocular Pathology ServicesL.V. Prasad Eye InstituteHyderabadIndia

Personalised recommendations